VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease
Open Access
- 13 April 2023
- journal article
- research article
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 43 (23) , 4365-4377
Abstract
Huntington's disease (HD) is an autosomal-dominant neurodegenerative disease characterized by progressive motor and cognitive impairments, with no disease-modifying therapies yet available. HD pathophysiology involves evident impairment in glutamatergic neurotransmission leading to severe striatal neurodegeneration. The vesicular glutamate transporter-3 (VGLUT3) regulates the striatal network that is centrally affected by HD. Nevertheless, current evidence on the role of VGLUT3 in HD pathophysiology is lacking. Here, we crossed mice lacking Slc17a8 gene ( VGLUT3 –/– ) with heterozygous zQ175 knock-in mouse model of HD ( zQ175:VGLUT3 –/– ). Longitudinal assessment of motor and cognitive functions from 6 to 15 months of age reveals that VGLUT3 deletion rescues motor coordination and short-term memory deficits in both male and female zQ175 mice. VGLUT3 deletion also rescues neuronal loss likely via the activation of Akt and ERK1/2 in the striatum of zQ175 mice of both sexes. Interestingly, the rescue in neuronal survival in zQ175:VGLUT3 –/– mice is accompanied by a reduction in the number of nuclear mutant huntingtin (mHTT) aggregates with no change in the total aggregate levels or microgliosis. Collectively, these findings provide novel evidence that VGLUT3, despite its limited expression, can be a vital contributor to HD pathophysiology and a viable target for HD therapeutics. SIGNIFICANCE STATEMENT Dysregulation of the striatal network centrally contributes to the pathophysiology of Huntington's disease (HD). The atypical vesicular glutamate transporter-3 (VGLUT3) has been shown to regulate several major striatal pathologies, such as addiction, eating disorders, or L-DOPA-induced dyskinesia. Yet, our understanding of VGLUT3's role in HD remains unclear. We report here that deletion of the Slc17a8 ( Vglut3 ) gene rescues the deficits in both motor and cognitive functions in HD mice of both sexes. We also find that VGLUT3 deletion activates neuronal survival signaling and reduces nuclear aggregation of abnormal huntingtin proteins and striatal neuron loss in HD mice. Our novel findings highlight the vital contribution of VGLUT3 in HD pathophysiology that can be exploited for HD therapeutic management.Keywords
Funding Information
- CIHR (PJT-148656, PJT-165967, PJT-178060)
- Krembil Foundation
This publication has 95 references indexed in Scilit:
- Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's DiseasePLOS ONE, 2012
- Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175PLOS ONE, 2012
- Cognitive Impairment in Huntington Disease: Diagnosis and TreatmentCurrent Neurology and Neuroscience Reports, 2011
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- Cholinergic Interneurons Mediate Fast VGluT3-Dependent Glutamatergic Transmission in the StriatumPLOS ONE, 2011
- Group II Metabotropic Glutamate Receptor Agonist Ameliorates MK801-Induced Dysfunction of NMDA Receptors via the Akt/GSK-3β Pathway in Adult Rat Prefrontal CortexNeuropsychopharmacology, 2011
- Brain networks in Huntington diseaseJournal of Clinical Investigation, 2011
- Abnormal Motor Cortex Excitability in Preclinical and Very Early Huntington's DiseaseBiological Psychiatry, 2009
- Phosphorylation of huntingtin reduces the accumulation of its nuclear fragmentsMolecular and Cellular Neuroscience, 2009
- Chemically Specific Circuit Composed of Vesicular Glutamate Transporter 3- and Preprotachykinin B-producing Interneurons in the Rat NeocortexCerebral Cortex, 2004